T

Tyche Industries Ltd
BSE:532384

Watchlist Manager
Tyche Industries Ltd
BSE:532384
Watchlist
Price: 120 INR -0.87% Market Closed
Market Cap: 1.2B INR

Tyche Industries Ltd
Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Tyche Industries Ltd
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
T
Tyche Industries Ltd
BSE:532384
Revenue
₹633.5m
CAGR 3-Years
-1%
CAGR 5-Years
-3%
CAGR 10-Years
0%
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Revenue
₹343.1B
CAGR 3-Years
15%
CAGR 5-Years
14%
CAGR 10-Years
16%
Cipla Ltd
NSE:CIPLA
Revenue
₹283.5B
CAGR 3-Years
9%
CAGR 5-Years
9%
CAGR 10-Years
8%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Revenue
₹549.6B
CAGR 3-Years
10%
CAGR 5-Years
11%
CAGR 10-Years
8%
Lupin Ltd
NSE:LUPIN
Revenue
₹247.5B
CAGR 3-Years
16%
CAGR 5-Years
11%
CAGR 10-Years
7%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Revenue
₹122.5B
CAGR 3-Years
11%
CAGR 5-Years
9%
CAGR 10-Years
7%
No Stocks Found

Tyche Industries Ltd
Glance View

Market Cap
1.2B INR
Industry
Pharmaceuticals

Tyche Industries Ltd. engages in the manufacture and processing of active pharmaceutical ingredients and intermediates. The company is headquartered in Hyderabad, Telangana. The company went IPO on 2000-09-25. The firm primarily manufactures bulk drug intermediates. Its APIs include Sertraline HCI, Racecadotril, Palonosetron HCI, Silodosin, Solifenacin Succinate, Tamsulosin HCI, Tenofovir Disoproxil Fumarate, Tenofovir Alafenamide Fumarate, Atazanavir, Rupatadine Fumarate, Glucosamine HCI, Glucosamine Sulfate KCL, Glucosamine Sulfate NaCl, Nitrofurantoin Monohydrate, Nitrofurantoin Anhydrous and Nitrofurantoin Macrocrystal. Its intermediaries include 6-Methoxy-2-(4-methoxyphenyl)benzo[b]thiophene, 3-Fluoro-4-methoxy acetophenone, 3-Hydroxymethyl quinuclidine HCl, (RS)-3-Quinuclidinol, 3-Quinuclidinone Hydrochloride and 1-Benzylpiperidine-4-Carboxaldehyde (BPCA). Its nutraceuticals include Glucosamine Hydrochloride, Glucosamine Sulfate Potassium Chloride and Glucosamine Sulfate Sodium Chloride.

TYCHE Intrinsic Value
120.6 INR
Fairly Valued
Intrinsic Value
Price
T

See Also

What is Tyche Industries Ltd's Revenue?
Revenue
633.5m INR

Based on the financial report for Jun 30, 2025, Tyche Industries Ltd's Revenue amounts to 633.5m INR.

What is Tyche Industries Ltd's Revenue growth rate?
Revenue CAGR 10Y
0%

Over the last year, the Revenue growth was -7%. The average annual Revenue growth rates for Tyche Industries Ltd have been -1% over the past three years , -3% over the past five years .

Back to Top